Princeton, CINJ Partner on Cancer Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Princeton University and the Cancer Institute of New Jersey will use microarray and mass spectrometry technologies to discover more about what enables cancer tumor cells to become resistant to some treatments by becoming dormant and self-cannibalizing to survive periods of stress.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.